Morningstar chairman Mansueto sells 7,250 shares
The 78-share transaction was executed in multiple trades priced from $244.4100 to $245.3400.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
4
Rhea-AI Filing Summary
Morningstar, Inc. Executive Chairman Joseph D. Mansueto sold 7,250 shares of common stock on November 5, 2026, in five reported transactions. The reported transaction prices ranged from $244.9633 to $248.7800 per share. The sales were made under a Rule 10b5-1 trading plan adopted June 8, 2026.
Insider Trade Summary 10b5-1
Net Seller: 7,250 shares
Net Sell
5 txns
Insider
Mansueto Joseph D
Role
Executive Chairman
Sold
7,250 shs ($1.79M)
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Common Stock F1, F2 | 78 | $244.9633 | $19K |
| Sale | Common Stock F1, F3 | 1,896 | $246.1261 | $467K |
| Sale | Common Stock F1, F4 | 2,932 | $246.9146 | $724K |
| Sale | Common Stock F1, F5 | 2,248 | $247.7721 | $557K |
| Sale | Common Stock F1 | 96 | $248.78 | $24K |
| Holding | Common Stock F6 | -- | -- | -- |
| Holding | Common Stock F7 | -- | -- | -- |
Holdings After Transaction:
Common Stock — 8,587,179 shares (Direct);
Common Stock — 5,750,034 shares (Indirect, By Trust)
Footnotes (7)
- F1. The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 8, 2026.
- F2. The transaction was executed in multiple trades at prices ranging from $244.4100 to $245.3400. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide upon request to the SEC staff, Morningstar or a shareholder of Morningstar full information regarding the number of shares and prices at which the transaction was effected.
- F3. The transaction was executed in multiple trades at prices ranging from $245.4900 to $246.4800. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide upon request to the SEC staff, Morningstar or a shareholder of Morningstar full information regarding the number of shares and prices at which the transaction was effected.
- F4. The transaction was executed in multiple trades at prices ranging from $246.4900 to $247.4500. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide upon request to the SEC staff, Morningstar or a shareholder of Morningstar full information regarding the number of shares and prices at which the transaction was effected.
- F5. The transaction was executed in multiple trades at prices ranging from $247.4950 to $248.4400. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide upon request to the SEC staff, Morningstar or a shareholder of Morningstar full information regarding the number of shares and prices at which the transaction was effected.
- F6. The shares are held in grantor retained annuity trusts for the benefit of the reporting person and his children. The reporting person serves as trustee of the grantor retained annuity trusts.
- F7. The shares are held in trusts for the benefit of the reporting person's children. The reporting person's spouse is trustee of the trusts.
Key Figures
Total shares sold: 7,250 shares
78-share transaction: 78 shares at $244.9633 per share
1,896-share transaction: 1,896 shares at $246.1261 per share
+3 more
6 metrics
Total shares sold
7,250 shares
November 5, 2026
78-share transaction
78 shares at $244.9633 per share
November 5, 2026; reported weighted-average price
1,896-share transaction
1,896 shares at $246.1261 per share
November 5, 2026; reported weighted-average price
2,932-share transaction
2,932 shares at $246.9146 per share
November 5, 2026; reported weighted-average price
2,248-share transaction
2,248 shares at $247.7721 per share
November 5, 2026; reported weighted-average price
96-share transaction
96 shares at $248.7800 per share
November 5, 2026
Key Terms
Rule 10b5-1 trading plan, weighted average sales price, grantor retained annuity trusts
3 terms
Rule 10b5-1 trading plan regulatory
"pursuant to a Rule 10b5-1 trading plan"
A Rule 10b5-1 trading plan is a pre-arranged schedule that allows company insiders to buy or sell stock at specific times, even if they have inside information. It helps prevent accusations of unfair trading by making these transactions look planned and transparent, rather than sneaky or illegal.
weighted average sales price financial
"reflects the weighted average sales price"
grantor retained annuity trusts financial
"held in grantor retained annuity trusts"
A grantor retained annuity trust (GRAT) is an estate-planning tool where an owner transfers assets into a trust and receives fixed payments back for a set number of years; any remaining assets after that period pass to designated beneficiaries. For investors it matters because it can move future investment growth to heirs while potentially reducing gift and estate taxes — like putting a rising asset in a timed box that pays you first and gives the remaining upside to others.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
Were Joseph D. Mansueto's MORN sales made under a trading plan?
Yes. The sales were effected pursuant to a Rule 10b5-1 trading plan adopted on June 8, 2026.
AI-generated analysis. How Rhea-AI works. Not financial advice.
